- Home
- NBIX vs AUR Comparison
NBIX vs AUR Comparison
Compare NBIX & AUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- AUR
- Stock Information
- Founded
- NBIX 1992
- AUR 2017
- Country
- NBIX United States
- AUR United States
- Employees
- NBIX N/A
- AUR N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- AUR EDP Services
- Sector
- NBIX Health Care
- AUR Technology
- Exchange
- NBIX Nasdaq
- AUR Nasdaq
- Market Cap
- NBIX 11.0B
- AUR 10.4B
- IPO Year
- NBIX 1996
- AUR N/A
- Fundamental
- Price
- NBIX $115.71
- AUR $7.28
- Analyst Decision
- NBIX Strong Buy
- AUR Buy
- Analyst Count
- NBIX 20
- AUR 9
- Target Price
- NBIX $163.20
- AUR $10.13
- AVG Volume (30 Days)
- NBIX 1.9M
- AUR 14.1M
- Earning Date
- NBIX 05-05-2025
- AUR 05-08-2025
- Dividend Yield
- NBIX N/A
- AUR N/A
- EPS Growth
- NBIX N/A
- AUR N/A
- EPS
- NBIX 2.96
- AUR N/A
- Revenue
- NBIX $2,412,600,000.00
- AUR N/A
- Revenue This Year
- NBIX $15.36
- AUR N/A
- Revenue Next Year
- NBIX $16.34
- AUR $804.94
- P/E Ratio
- NBIX $39.13
- AUR N/A
- Revenue Growth
- NBIX 21.73
- AUR N/A
- 52 Week Low
- NBIX $84.23
- AUR $2.10
- 52 Week High
- NBIX $157.98
- AUR $10.77
- Technical
- Relative Strength Index (RSI)
- NBIX 60.88
- AUR 53.02
- Support Level
- NBIX $105.45
- AUR $7.11
- Resistance Level
- NBIX $130.46
- AUR $8.25
- Average True Range (ATR)
- NBIX 4.31
- AUR 0.59
- MACD
- NBIX 1.96
- AUR 0.08
- Stochastic Oscillator
- NBIX 50.22
- AUR 59.75
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About AUR Aurora Innovation Inc.
Aurora Innovation Inc is engaged in delivering self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles, and underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, an advanced and scalable suite of self-driving hardware, software and data services designed as a platform to adapt and interoperate amongst vehicle types and applications.